QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PBYI

QT73Puma Biotechnology, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
7.56
+0.33+4.56%
OverviewShort InterestFilings
PBYIQT73Puma Biotechnology, Inc.·NASDAQ
OverviewShort InterestFilings
7.56+4.56%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E15.08EPS (ttm)
0.48
Insider Own-
Shs Outstand-
Perf Week4.56%
Market Cap368.00MForward P/E37.80EPS next Y0.20Insider Trans-Shs Float-Perf Month11.01%
Enterprise Value347.76MPEG-EPS next Q0.07Inst Own-Short Float-Perf Quarter22.93%
Income24.40MP/S1.62EPS this Y-39.58%Inst Trans-Short Ratio-Perf Half Y33.33%
Sales227.17MP/B2.86EPS next Y-31.03%ROA12.65%Short Interest-Perf YTD27.06%
Book/sh-P/C6.86EPS next 5Y-ROE20.37%52W High7.90 -4.30%Perf Year120.41%
Cash/sh-P/FCF6.87EPS past 3/5Y-ROIC17.12%52W Low3.03 149.50%Perf 3Y-
Dividend Est.-EV/EBITDA7.74Sales past 3/5Y0.00% 0.27%Gross Margin74.46%Volatility3.10% 2.59%Perf 5Y-
Dividend TTM-EV/Sales1.53EPS Y/Y TTM-1.61%Oper. Margin12.98%ATR (14)0.29Perf 10Y-
Dividend Ex-Date-Quick Ratio2.38Sales Y/Y TTM-1.74%Profit Margin10.73%RSI (14)61.31Recom2.79
Dividend Gr. 3/5Y-Current Ratio2.38EPS Q/Q-140.00%SMA206.05%Beta0.74Target Price-
Payout0.00%Debt/Eq0.12Sales Q/Q-2.17%SMA504.07%Rel Volume1.68Prev Close7.23
Employees172LT Debt/Eq0.08EarningsAug 06SMA20023.35%Avg Volume253.76KPrice7.56
IPO DateApr 24, 2012Option/ShortYes / YesEPS/Sales Surpr.69.23% 7.14%Net Debt/EBITDA-0.45Volume427,438Change4.56%
Analyst Ratings
DateActionAnalystRatingTarget
Sep-28-21UpgradeCitigroupNeutral → Buy
Oct-08-19DowngradeGoldman SachsNeutral → Sell
May-10-19DowngradeCitiBuy → Neutral
May-10-19DowngradeCantor FitzgeraldOverweight → Neutral
May-10-19DowngradeCitigroupBuy → Neutral
Jan-03-19DowngradeGuggenheimBuy → Neutral
Nov-19-18UpgradeGoldman SachsSell → Neutral
Nov-02-18DowngradeBarclaysEqual Weight → Underweight
Apr-12-18DowngradeBarclaysOverweight → Equal Weight
Jan-24-18DowngradeCowen & Co.Outperform → Market Perform
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue226228230
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A575864
Gross Profit168170166
Selling, General and Administrative Excl. Other717180
Research and Development686255
Other Operating Expense000
Operating Income303731
Interest Expense5712
Unusual Expense
———
Non-Operating Income (Expense)-4-5-6
Net Income Before Taxes293624
Income Taxes45-6
Consolidated Net Income243130
Net Income From Continuing Operations243130
Net Income243130
EPS (Recurring)0.500.620.62
EPS (Basic, Before Extraordinaries)0.500.620.62
EPS (Diluted)0.480.610.62
EBITDA455348
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio15.759.75—
Price To Sales Ratio1.711.30—
Gross Margin74.3474.5672.17
Operating Margin13.2716.2313.48
Net Margin10.6213.6013.04
Shares Outstanding515049
Market Capitalization386298—
Operating Lease Expense
———
Insider Trading Volume
$8.12$7.04$5.95$4.86$3.78● Close Price0.00K143.19K286.37K429.56K572.75KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
WILSON TROY EDWARDDirectorJun 12 '26Sale7.2010,80077,74859,750Jun 15 12:00 AM
MOYES JAY MDirectorJun 12 '26Sale7.2222,000158,79658,322Jun 15 12:00 AM
Senderowicz AdrianDirectorJun 12 '26Sale7.2027,000194,31127,000Jun 15 12:00 AM
Dorval AllisonDirectorJun 12 '26Sale7.2011,61083,57990,780Jun 15 12:00 AM
Stuglik Brian MDirectorJun 12 '26Sale7.208,10058,311113,858Jun 15 12:00 AM
HUNT DOUGLAS MSee RemarksJan 07 '26Sale5.885,01429,477155,907Jan 08 12:00 AM
AUERBACH ALAN HPresident and CEOJan 07 '26Sale5.8818,012105,8937,145,951Jan 08 12:00 AM
NOUGUES MAXIMO FChief Financial OfficerJan 07 '26Sale5.886,40537,655193,284Jan 08 12:00 AM
AUERBACH ALAN HPresident and CEOJan 06 '26Sale5.8416,93898,9867,163,963Jan 08 12:00 AM
HUNT DOUGLAS MSee RemarksJan 06 '26Sale5.843,97323,218160,921Jan 08 12:00 AM
NOUGUES MAXIMO FChief Financial OfficerJan 06 '26Sale5.844,54026,532199,689Jan 08 12:00 AM
MILLER MICHAEL PATRICKDirectorNov 11 '25Sale4.8620,00097,22854,000Nov 13 12:00 AM
Cesano AlessandraDirectorJul 18 '25Sale3.3727,00090,90941,850Jul 22 12:00 AM
HUNT DOUGLAS MSee RemarksJul 09 '25Sale3.543,44312,171164,894Jul 10 12:00 AM
NOUGUES MAXIMO FChief Financial OfficerJul 09 '25Sale3.543,93513,910204,229Jul 10 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR